Resumen:
Abstract
Introduction: Headache epidemiological studies in Latin America are scarce, and available data suggest that medication
overuse headache is an existing health concern in the region.
Materials and Methods: A survey empirically constructed to assess the management of medication overuse headache
was sent to all the International Headache Society (IHS) members from Latin American countries.
Results: We found no IHS members in 13 countries of Latin America. In countries with active members, the median
number of IHS members per million inhabitants was significantly less when compared to Western Europe. Although the
International Classification of Headache Disorders-3-beta (ICHD-3-beta) criterion was the most frequently used tool for
medication overuse headache diagnosis, 41% of responders considered the diagnostic criterion ‘ambiguous’ and only 67%
found them ‘very useful’. With respect to preferred treatment patterns, an important lack of uniformity, and a very limited
usage of therapeutic approaches widely employed in other regions, characterized the responses.
Conclusion: There is an urgent need to reach a consensus and establish region-specific strategies for the management of
medication overuse headache as well as other headache disorders in this region. Development of headache specialized
educational programmes, and participation of Latin American health providers in the IHS, should be incentivized.